Presentation of a 3D conformal radiotherapy technique for head-and-neck tumors resulting in substantial protection of the parotid glands;Etablierung einer 3D-konformationstechnik zur radiotherapie von Kopf-Hals-Tumoren unter berücksichtigung der parotisschonung

Strahlentherapie und Onkologie

Volumn 182, Issue 6, 2006, Pages 325-330

  Kuhnt, Thomas ^a,c   Janich, Martin ^a   Götz, Uwe ^b   Gerlach, Reinhard ^a   Chiricuta, Ion Christian ^b   Hänsgen, Gabriele ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b St Vincenz Krankenhaus Limburg   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

3D conformal radiotherapy technique; Head and neck tumors; Parotid gland protection

Indexed keywords

ARTICLE; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; ELECTRON THERAPY; HEAD AND NECK CANCER; HUMAN; OROPHARYNX CARCINOMA; PAROTID GLAND; PHOTON THERAPY; RADIATION DOSE; RADIATION FIELD; RADIATION PROTECTION; THREE DIMENSIONAL IMAGING; XEROSTOMIA;

HEAD AND NECK NEOPLASMS; HUMANS; PAROTID DISEASES; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 33646545722     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1527-7     Document Type: Article

References (9)

1. Beer KT, Zehnder D, Lussi A, et al. Sparing of contralateral major salivary glands has a significant effect on oral health in patients treated with radical radiotherapy of head and neck tumors. Strahlenther Onkol 2002;178:722-6.
2. Eisbruch A, Ship JA, Dawson LA, et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 2003;27:832-7.
3. Janda M, Newman B, Obermair A. Impaired quality of life in patients commencing radiotherapy for cancer. Strahlenther Onkol 2004;180:78-83.
4. Konings AW, Cotteleer F, Faber H, et al. Volume effects and region-dependent radiosensitivity of the parotid gland. Int J Radiat Oncol Biol Phys 2005;62:1090-5.
5. Kuhnt T, Jirsak N, Müller AC, et al. Quantitative und qualitative Speicheldrüsenfunktionsuntersuchungen in Abhängigkeit von Dosis und Volumen einer Radiotherapie zur Verringerung der Xerostomie bei Kopf-Hals-Tumoren. Strahlenther Onkol 2005;181:520-8.
6. Momm F, Volegova-Neher NJ, Schulte-Monting J, et al. Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study. Strahlenther Onkol 2005;181:231-6.
7. Roesink JM, Moerland MA, Battermann JJ, et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 2001;51:938-46.
8. Salz H, Wiezorek T, Scheithauer M, et al. IMRT with compensators for head-and-neck cancers. Treatment technique, dosimetric accuracy, and practical experiences. Strahlenther Onkol 2005;181:665-72.
9. Wiggenraad R, Mast M, van Santvoort J, et al. ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT. Strahlenther Onkol 2005;181:673-82.